Evidence map›Paper›PMID 27481517›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.

Li Yu, Xin Li, Haibin Li, Huixin Chen, Hua Liu

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Target c-Myc to treat pancreatic cancer.Cancer biology & therapy · 2022
    Article
  7. Article
  8. Rab11FIP1-deficient mice develop spontaneous inflammation and show increased susceptibility to colon damage.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  9. Article
  10. Article
  11. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Endosomal Recycling Pathway-At the Crossroads of the Cell.International journal of molecular sciences · 2020
    Review
  18. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.Cellular oncology (Dordrecht, Netherlands) · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Li YuDepartment of Physiology, Jinzhou Medical University, Jinzhou, Liaoning, China. Liyuliaoyi@163.com.
Xin LiThe Central Hospital of Jinzhou, Liaoning, China.
Haibin LiDepartment of Ophthalmology, The Third Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Huixin ChenDepartment of Ophthalmology, The Third Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
Hua LiuKey Laboratory of Age-Related Macular Degeneration, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. liuhua_jinzhou2016@163.com.
Jinzhou Medical University · CNJinzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rab family GTPases regulate many major biological processes during tumor progression such as cell proliferation, cytoskeleton organization, cell movement, and invasion. The present study aims to examine the clinical significance, biological roles, and molecular mechanism of Rab11a in pancreatic cancer progression. We examined expression pattern of Rab11a in 96 cases of pancreatic cancer specimens using immunohistochemistry and found Rab11a overexpression correlated with tumor-node-metastasis (TNM) stage (p = 0.0111). We depleted Rab11a in Bxpc3 cells using small interfering RNA (siRNA) and overexpressed Rab11a in Capan2 cells. Knockdown of Rab11a inhibited cell growth, invasion, and cell cycle progression while its overexpression facilitated cell growth, invasion, and cell cycle progression. In addition, Rab11a overexpression increased gemcitabine resistance and inhibited gemcitabine-induced apoptosis in Capan2 cells while its depletion reduced drug resistance. We investigated the role of Rab11a in the regulation of Wnt/β-catenin signaling and we demonstrated that Rab11a overexpression upregulated GSK3β phosphorylation and nuclear β-catenin accumulation. Rab11a depletion inhibited while its overexpression enhanced β-catenin/T-cell factor (TCF) transcriptional activity with corresponding change of Wnt target genes including cyclin D1, cyclin E, MMP7, and c-myc. Wnt inhibitor (FH535) partly attenuated the effects of Rab11a on cell proliferation and Wnt target genes. In conclusion, the present study demonstrated that Rab11a promotes aggressiveness of pancreatic cancer through GSK3β/Wnt/β-catenin signaling pathway.

Indexed as

Apoptosisbeta CateninBiomarkers, TumorBlotting, WesternCase-Control StudiesCell CycleCell ProliferationFemaleFlow CytometryFluorescent Antibody TechniqueFollow-Up StudiesGene Expression Regulation, NeoplasticGlycogen Synthase Kinase 3 betaHumansImmunoenzyme TechniquesMalebeta CateninBiomarkers, TumorCTNNB1 protein, humanGlycogen Synthase Kinase 3 betarab11 GTP-Binding Proteinsrab GTP-Binding ProteinsRNA, MessengerWnt ProteinsChemoresistancePancreatic cancerRab11aWnt

Identifiers

PMID27481517
OpenAlexW2489537049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.